undamentalytics Newsletter

Irhythm Holdings, Inc. balance sheet

At the end of fiscal 2025, Irhythm Holdings, Inc. had total assets of $1.02bn, total liabilities of $867m and shareholders' equity of $153m. It held $236m in cash against $650m of debt: net debt of $413m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Irhythm Holdings, Inc.: balance sheet, annual
Fiscal year2014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents9255292020891287936420236247
Receivables—6913202430465061807684
Inventory—112245101514142223
Total current assets—33119120104173378306289231646703756
Goodwill—111111111111
Total assets—381381331183065124634484339311,0201,093
Accounts payable—12228411867217
Deferred revenue (current)—111111333344
Total current liabilities—913213052668889107111152196
Short-term debt———10212120————
Long-term debt—313232353321103535646650651
Total debt0314645353533213535646650651
Total liabilities—42465465171170183208223841867907
Shareholders' equity−81−10293795213534228024021091153186
Non-controlling interests and other (assets − liabilities − equity)—97———————————
Net debt (negative = net cash)−95−5361514−56−106−44−1227413404
Shares outstanding—6m—23m24m27m29m29m30m31m31m32m33m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: IRTC vs OFIXATEC vs IRTCIRTC vs MYGN

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Irhythm Holdings, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Irhythm Holdings, Inc.